Equities research analysts expect that Tivity Health Inc (NASDAQ:TVTY) will announce sales of $246.99 million for the current quarter, Zacks Investment Research reports. Five analysts have made estimates for Tivity Health’s earnings. The lowest sales estimate is $237.85 million and the highest is $267.98 million. Tivity Health posted sales of $303.90 million in the same quarter last year, which would indicate a negative year-over-year growth rate of 18.7%. The company is scheduled to issue its next earnings report on Tuesday, November 10th.
On average, analysts expect that Tivity Health will report full-year sales of $1.09 billion for the current year, with estimates ranging from $1.07 billion to $1.11 billion. For the next financial year, analysts expect that the firm will report sales of $1.22 billion, with estimates ranging from $1.15 billion to $1.28 billion. Zacks’ sales calculations are an average based on a survey of sell-side research firms that that provide coverage for Tivity Health.
Tivity Health (NASDAQ:TVTY) last released its quarterly earnings results on Wednesday, August 5th. The company reported $0.79 earnings per share for the quarter, beating analysts’ consensus estimates of $0.25 by $0.54. Tivity Health had a negative net margin of 40.68% and a positive return on equity of 36.30%.
A number of analysts have recently weighed in on the stock. Guggenheim assumed coverage on shares of Tivity Health in a report on Friday, June 12th. They issued a “neutral” rating on the stock. Barrington Research raised their price target on shares of Tivity Health from $15.00 to $27.00 and gave the company an “outperform” rating in a report on Thursday, August 6th. Craig Hallum upgraded shares of Tivity Health from a “hold” rating to a “buy” rating and raised their price target for the company from $10.00 to $20.00 in a report on Thursday, August 6th. BidaskClub cut shares of Tivity Health from a “strong-buy” rating to a “buy” rating in a research note on Wednesday. Finally, Zacks Investment Research upgraded shares of Tivity Health from a “sell” rating to a “strong-buy” rating and set a $19.00 target price for the company in a research note on Thursday, August 13th. One analyst has rated the stock with a sell rating, seven have assigned a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company’s stock. The company currently has an average rating of “Hold” and an average target price of $18.67.
Institutional investors and hedge funds have recently bought and sold shares of the business. PNC Financial Services Group Inc. raised its position in Tivity Health by 154.4% during the 2nd quarter. PNC Financial Services Group Inc. now owns 2,447 shares of the company’s stock worth $28,000 after buying an additional 1,485 shares during the last quarter. Point72 Hong Kong Ltd raised its position in Tivity Health by 57.4% during the 2nd quarter. Point72 Hong Kong Ltd now owns 2,577 shares of the company’s stock worth $29,000 after buying an additional 940 shares during the last quarter. Bank of Montreal Can raised its position in Tivity Health by 359.7% during the 2nd quarter. Bank of Montreal Can now owns 4,905 shares of the company’s stock worth $52,000 after buying an additional 3,838 shares during the last quarter. Public Employees Retirement Association of Colorado raised its position in Tivity Health by 21.6% during the 1st quarter. Public Employees Retirement Association of Colorado now owns 12,658 shares of the company’s stock worth $80,000 after buying an additional 2,248 shares during the last quarter. Finally, GSA Capital Partners LLP purchased a new position in Tivity Health during the 1st quarter worth approximately $89,000. 99.21% of the stock is owned by institutional investors.
NASDAQ:TVTY opened at $14.10 on Thursday. Tivity Health has a fifty-two week low of $1.92 and a fifty-two week high of $26.07. The stock has a market capitalization of $684.70 million, a P/E ratio of -1.42, a P/E/G ratio of 1.02 and a beta of 2.32. The company has a debt-to-equity ratio of 26.60, a quick ratio of 0.81 and a current ratio of 0.96. The company’s 50-day simple moving average is $15.80 and its 200-day simple moving average is $10.88.
Tivity Health Company Profile
Tivity Health, Inc provides fitness and health improvement programs in the United States. The company offers SilverSneakers senior fitness program to the members of Medicare advantage, Medicare supplement; and Prime fitness, a fitness facility access program through commercial health plans and employers.
Read More: Beige Book
Get a free copy of the Zacks research report on Tivity Health (TVTY)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Tivity Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tivity Health and related companies with MarketBeat.com's FREE daily email newsletter.